State LA
Clinical Trials in Louisiana
Recruiting clinical trials with at least one study location in Louisiana. Data updated daily from ClinicalTrials.gov.
Top Conditions in Louisiana
Malignant Solid Neoplasm (4)Lung Non-Small Cell Carcinoma (2)Melanoma (2)Non-Hodgkin Lymphoma (2)Chronic Lymphocytic Leukemia (2)Hidradenitis Suppurativa (2)Hematopoietic and Lymphatic System Neoplasm (2)Acute Myeloid Leukemia (2)Pressure Injury (2)Cardiovascular Diseases (2)Overweight (2)Obesity (2)
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05412927 N/A
Recruiting
AngelMed Guardian® System PMA Post Approval Study
Condition
Acute Coronary Syndrome
Enrollment
500 pts
Location
United States
Sponsor
Angel Medical Systems
NCT06225596 Phase 2, Phase 3
Recruiting
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial ...
Condition
Metastatic Urothelial Cancer
Enrollment
956 pts
Location
United States, Argentina, Australia
Sponsor
BicycleTx Limited
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT04592445 N/A
Recruiting
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having H...
Condition
Heart Failure With Preserved Ejection Fraction (HFpEF
Enrollment
150 pts
Location
United States
Sponsor
Axon Therapies, Inc.
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06312722 N/A
Recruiting
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market S...
Condition
Benign Prostatic Hyperplasia
Enrollment
92 pts
Location
United States
Sponsor
Urotronic Inc.
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT06239272 Phase 1, Phase 2
Recruiting
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin...
Condition
Adipocytic Neoplasm
Enrollment
139 pts
Location
United States
Sponsor
St. Jude Children's Research H
NCT05304767 Phase 3
Recruiting
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive Kar...
Condition
Schizophrenia
Enrollment
280 pts
Location
United States, Bulgaria, Czechia
Sponsor
Karuna Therapeutics, Inc., a B
NCT06151405 N/A
Recruiting
Nutrition for Asthmatics
Condition
Asthma
Enrollment
15 pts
Location
United States
Sponsor
Pennington Biomedical Research
NCT06979531 Phase 2
Recruiting
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Di...
Condition
Primary Sjögren's Syndrome
Enrollment
180 pts
Location
United States, Argentina, Brazil
Sponsor
Immunovant Sciences GmbH
NCT07018700 Phase 3
Recruiting
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preve...
Condition
Episodic Migraine
Enrollment
990 pts
Location
United States, Austria, Czechia
Sponsor
Merz Therapeutics GmbH
NCT07061964 Phase 2
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Rem...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
111 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06378632 N/A
Recruiting
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE ...
Condition
Heart Failure
Enrollment
500 pts
Location
United States, Israel, Spain
Sponsor
Cordio Medical
NCT04284436 N/A
Recruiting
Study in Parkinson Disease of Exercise
Condition
Parkinson Disease
Enrollment
370 pts
Location
United States, Canada
Sponsor
Northwestern University
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06637644 N/A
Recruiting
Impella RP Flex with Smart Assist
Condition
Right Ventricular (RV) Dysfunction
Enrollment
200 pts
Location
United States
Sponsor
Abiomed Inc.
NCT05126277 Phase 3
Recruiting
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With ...
Condition
Lupus Nephritis
Enrollment
462 pts
Location
United States, Argentina, Brazil
Sponsor
Novartis Pharmaceuticals
NCT06486428 N/A
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In
NCT06570798 Phase 2
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune ...
Condition
Systemic Lupus Erythematosus
Enrollment
220 pts
Location
United States, Australia, Belgium
Sponsor
Amgen
NCT05050136 Phase 2
Recruiting
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixib...
Condition
Primary Biliary Cholangitis
Enrollment
260 pts
Location
United States, Argentina, Belgium
Sponsor
Mirum Pharmaceuticals, Inc.
NCT07207811 Phase 3
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine...
Condition
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Enrollment
1,280 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT07296419 N/A
Recruiting
Dual System Study: Transvaginal Fetal Pulse Oximetry Measurement Systems
Condition
Fetal Hypoxia
Enrollment
15 pts
Location
United States
Sponsor
Raydiant Oximetry, Inc.